132 related articles for article (PubMed ID: 2825751)
1. Prognosis in small cell carcinoma of the lung--relationship to human milk fat globule 2 (HMFG2) antigen and other small cell associated antigens.
Allan SG; Hay FG; McIntyre MA; Leonard RC
Br J Cancer; 1987 Oct; 56(4):485-8. PubMed ID: 2825751
[TBL] [Abstract][Full Text] [Related]
2. Expression of human milk fat globule antigens HMFG1 and HMFG2 on ovarian tumours and lung tumours.
Hay FG; Leonard RC
Dis Markers; 1988 Mar; 6(1):29-39. PubMed ID: 2456176
[TBL] [Abstract][Full Text] [Related]
3. Immunocytological staining reactions of anti-carcinoembryonic antigen, Ca, and anti-human milk fat globule monoclonal antibodies on benign and malignant exfoliated mesothelial cells.
Ghosh AK; Butler EB
J Clin Pathol; 1987 Dec; 40(12):1424-7. PubMed ID: 3323250
[TBL] [Abstract][Full Text] [Related]
4. The ovarian-carcinoma-associated sebaceous gland antigen is a member of the HMFG2-positive family of epithelial mucins.
de Kretser T
Tumour Biol; 1988; 9(2-3):154-64. PubMed ID: 2456600
[TBL] [Abstract][Full Text] [Related]
5. The value of anticarcinoembryonic antigen, human milk factor globulin, and antikeratin antibodies in differentiating mesothelioma from lung carcinoma.
Joglekar VM; Oliver D; Harris M
Br J Ind Med; 1991 Jan; 48(1):34-7. PubMed ID: 1704251
[TBL] [Abstract][Full Text] [Related]
6. Modulation of the cluster 1 and mucin antigens in human small cell lung cancer and other epithelial tumour cell lines after treatment with the differentiation inducing agent, sodium butyrate.
Hay FG; Duncan LW; Langdon SP; Leonard RC
Br J Cancer Suppl; 1991 Jun; 14():33-5. PubMed ID: 1645568
[TBL] [Abstract][Full Text] [Related]
7. Quantitation of human milk fat globule (HMFG1) expression in breast carcinoma and its association with survival.
Parham DM; Slidders W; Robertson AJ
J Clin Pathol; 1988 Aug; 41(8):875-9. PubMed ID: 3170774
[TBL] [Abstract][Full Text] [Related]
8. Assessment of milk fat globule membrane antibodies and lectins as markers of short-term prognosis in breast cancer.
Walker RA
Br J Cancer; 1990 Sep; 62(3):462-6. PubMed ID: 2206956
[TBL] [Abstract][Full Text] [Related]
9. Expression of CEA, CA125, CA19-9 and human milk fat globule membrane antigen in ovarian tumours.
Macdonald F; Bird R; Stokes H; Russell B; Crocker J
J Clin Pathol; 1988 Mar; 41(3):260-4. PubMed ID: 3162916
[TBL] [Abstract][Full Text] [Related]
10. The assessment of in vitro modulation of milk fat globule membrane expression by human breast carcinomas.
Jones JL; Walker RA
J Pathol; 1987 Sep; 153(1):51-60. PubMed ID: 2444687
[TBL] [Abstract][Full Text] [Related]
11. The value of the human milk fat globule membrane antigen HMFG2 in epithelial ovarian cancer monitoring: comparison with CA125.
Fisken J; Roulston JE; Sturgeon C; Badley RA; Jönrup I; Aspinall L; Leonard RC
Br J Cancer; 1993 May; 67(5):1065-70. PubMed ID: 8494699
[TBL] [Abstract][Full Text] [Related]
12. Expression of myeloid and major histocompatibility antigens on small cell carcinoma of the lung cell lines analyzed by cytofluorography: modulation by gamma-interferon.
Ball ED; Sorenson GD; Pettengill OS
Cancer Res; 1986 May; 46(5):2335-9. PubMed ID: 3008987
[TBL] [Abstract][Full Text] [Related]
13. Expression of epithelial and neural antigens in small cell and non small cell lung carcinoma.
Moss F; Bobrow LG; Sheppard MN; Griffiths M; Rowe D; Beverley PC; Addis B; Souhami RL
J Pathol; 1986 Jun; 149(2):103-11. PubMed ID: 2426429
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of the monoclonal antibodies HMFG1 and HMFG2 in breast cancer.
Berry N; Jones DB; Smallwood J; Taylor I; Kirkham N; Taylor-Papadimitriou J
Br J Cancer; 1985 Feb; 51(2):179-86. PubMed ID: 2578285
[TBL] [Abstract][Full Text] [Related]
15. Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by a novel immunization approach.
Tong AW; Lee J; Stone MJ
Cancer Res; 1984 Nov; 44(11):4987-92. PubMed ID: 6207911
[TBL] [Abstract][Full Text] [Related]
16. The expression of milk fat globule antigens within human mammary tumours: relationship to steroid hormone receptors and response to endocrine treatment.
Baildam AD; Howell A; Barnes DM; Turnbull L; Sellwood RA
Eur J Cancer Clin Oncol; 1989 Mar; 25(3):459-67. PubMed ID: 2703000
[TBL] [Abstract][Full Text] [Related]
17. Relationship between CaMBr1 expression and tumor progression in small cell lung carcinomas.
Martignone S; Bedini AV; Ciavolella A; Ménard S; Patriarca C; Pilotti S; Ravasi G; Tagliabue E; Colnaghi MI
Tumori; 1989 Aug; 75(4):373-7. PubMed ID: 2554552
[TBL] [Abstract][Full Text] [Related]
18. Multi-parameter flow cytometric quantitation of the expression of the tumor-associated antigen SM3 in normal and neoplastic ovarian tissues. A comparison with HMFG1 and HMFG2.
van Dam PA; Lowe DG; Watson JV; Jobling TW; Chard T; Shepherd JH
Cancer; 1991 Jul; 68(1):169-77. PubMed ID: 2049739
[TBL] [Abstract][Full Text] [Related]
19. Circulating tumor-associated antigen detected by the monoclonal antibody HMFG2 in human epithelial ovarian cancer.
Ward BG; Cruickshank DJ
Int J Cancer; 1987 Jan; 39(1):30-3. PubMed ID: 3793268
[TBL] [Abstract][Full Text] [Related]
20. Study of the expression and function of the tumour-associated antigen CaMBr1 in small cell lung carcinomas.
Martignone S; Ménard S; Bedini A; Paccagnella A; Fasolato S; Veggian R; Colnaghi MI
Eur J Cancer; 1993; 29A(14):2020-5. PubMed ID: 7506562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
